Tampa General Hospital — Tampa, Florida

Public research footprint of Tampa General Hospital, compiled from the ClinicalTrials.gov public registry.

541

Registered studies

168

Active

Recruiting now

265

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Recurrent B Acute Lymphoblastic Leukemia · Spindle Cell Rhabdomyosarcoma · Hematopoietic and Lymphatic System Neoplasm

Recently updated registry entries

NCT04444921 — EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic… (Active Not Recruiting)
NCT05174169 — Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Tampa General Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.